Ranbaxy launches authorized generic version of Caduet in the US
Ranbaxy Laboratories Ltd. said its wholly-owned subsidiary Ranbaxy Pharmaceuticals Inc. had launched an authorized generic version of Caduet in the Us market, as part of an agreement with Pfizer Inc.
Pharmaceuticals major Ranbaxy Laboratories today said it had launched the generic versions of Atorvastatin tablets, 10mg, 20 mg, 40mg and 80mg in Italy and Sweden and 10mg, 20mg and 40mg in the Netherlands, after receiving approval from the respective local regulatory authorities.